home / stock / snoa / snoa news


SNOA News and Press, Sonoma Pharmaceuticals Inc. From 08/10/23

Stock Information

Company Name: Sonoma Pharmaceuticals Inc.
Stock Symbol: SNOA
Market: NASDAQ
Website: sonomapharma.com

Menu

SNOA SNOA Quote SNOA Short SNOA News SNOA Articles SNOA Message Board
Get SNOA Alerts

News, Short Squeeze, Breakout and More Instantly...

SNOA - Sonoma Pharmaceuticals GAAP EPS of -$0.29, revenue of $3.4M

2023-08-10 17:43:58 ET Sonoma Pharmaceuticals press release ( NASDAQ: SNOA ): FQ1 GAAP EPS of -$0.29. Revenue of $3.4M (-15.0% Y/Y). Shares -0.09% AH. For further details see: Sonoma Pharmaceuticals GAAP EPS of -$0.29, revenue of $3.4M

SNOA - Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial Results

Revenue increased 6% in the first fiscal quarter compared to the same period last year, excluding a one-time event last year Margins remained consistent year over year in an inflationary period, excluding the one-time event Sonoma continued to manage cash tightly, using only $0.3 millio...

SNOA - Sonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory Board

BOULDER, CO / ACCESSWIRE / August 3, 2023 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn ® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nas...

SNOA - Earnings week ahead: PepsiCo, Delta Airlines, JPMorgan, Citigroup, UnitedHealth and more

2023-07-07 11:08:15 ET Next week marks the start of a crucial period as earnings season kicks off, with major companies from the financial, consumer, and technology sectors all set to release their quarterly financial results. Among the list of firms scheduled to announce their financia...

SNOA - Sonoma Pharmaceuticals GAAP EPS of -$0.31, revenue of $3.01M

2023-06-22 08:58:37 ET Sonoma Pharmaceuticals press release ( NASDAQ: SNOA ): Q4 GAAP EPS of -$0.31. Revenue of $3.01M (+30.9% Y/Y). For further details see: Sonoma Pharmaceuticals GAAP EPS of -$0.31, revenue of $3.01M

SNOA - Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial Results

Revenues increased 31% in Q4 2023 compared to Q4 2022 Revenues increased 5% in FY 2023 compared to FY 2022 Net loss improved 56% quarter over quarter Net loss minus non-cash and one-time expenses decreased 65% quarter over quarter and 26% year over year BOULDER, CO / ACCESSWI...

SNOA - APRN, TIO and SNOA among pre-market losers

2023-06-12 08:13:25 ET Forza X1 ( FRZA ) -21% . Sientra ( SIEN ) -17% . Baosheng Media Group ( BAOS ) -11% . Blue Apron ( APRN ) -11% . MGO Global ( MGOL ) -10% . Medigus ( MDGS ) -8% . Nasdaq ( NDAQ ) -8% on ...

SNOA - Top Penny Stocks Trading Mistakes to Avoid 

2023-06-12 06:00:00 ET 3 Mistakes That Penny Stocks Traders Make The allure of penny stocks lies in their affordable price and high growth potential. Typically priced under $5 per share, penny stocks present an opportunity for substantial returns, even for investors operating with limit...

SNOA - Penny Stocks Trading and Options: Strategies for Leveraged Profits 

2023-06-11 11:00:00 ET 3 Tips for Options Trading With Penny Stocks Penny stocks, low-priced securities of small-cap companies, offer a unique investment landscape brimming with high-growth potential. Their lower price point allows for a wider range of investment possibilities, includin...

SNOA - Sonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European Union

BOULDER, CO / ACCESSWIRE / June 8, 2023 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn ® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, dermatology, a...

Previous 10 Next 10